Skip to main content

Day: August 30, 2023

Inside information: Aspocomp’s change negotiations at its Oulu plant have ended

Aspocomp Group Plc, Inside Information, August 30, 2023, at 8:45 a.m. Aspocomp’s change negotiations at its Oulu plant have ended. The goal of the negotiations was to prepare for a partial adjustment of production to correspond to temporarily low delivery volumes. As a result of the change negotiations, the company’s plan is to lay off 20-30 production blue-collar employees at a time for a maximum of 90 days during the next six months. For the first three months, 26 people will be temporarily laid off. At the start of the negotiations, the company estimated that the adaptation measures would lead to layoffs for a maximum of 90 days, and most of the Oulu plant’s approximately 120 production blue-collar employees were covered by the negotiations. Slower-than-expected recovery of the semiconductor cycle and high inventory levels in...

Continue reading

Zealand Pharma announces designation of priority review by the US FDA for dasiglucagon in congenital hyperinsulinism

Company announcement – No. 31 / 2023 Zealand Pharma announces designation of priority review by the US FDA for dasiglucagon in congenital hyperinsulinismUS FDA has granted priority review designation to dasiglucagon for the prevention and treatment of hypoglycemia in pediatric patients 7 days of age and older with congenital hyperinsulinism (CHI) for up to 3 weeks of dosing with a Prescription Drug User Fee Act (PDUFA) date on December 30, 2023. To ensure the most efficient regulatory process, the review by the US FDA will be conducted in two parts under the same New Drug Application (NDA). Part 1 relates to dosing for up to 3 weeks, whereas Part 2 relates to use beyond 3 weeks. The PDUFA date for Part 2 will be set following submission of additional analyses from existing datasets requested by the US FDA, which is expected before the...

Continue reading

DMG Blockchain Solutions Reports Third Quarter Results Ending June 30, 2023

VANCOUVER, British Columbia, Aug. 29, 2023 (GLOBE NEWSWIRE) — DMG Blockchain Solutions Inc. (TSX-V: DMGI) (OTCQB US: DMGGF) (FRANKFURT: 6AX) (“DMG”), a vertically integrated blockchain and cryptocurrency technology company, today announces its third quarter 2023 auditor reviewed financial results. All financial references are in Canadian Dollars unless specified otherwise. Recent HighlightsRevenue of $7.5 million, 195.7 mined bitcoin on 0.8 EH/s of realized hashrate, net loss of $4.3 million, $0.03 net loss per share Cash and digital currency of $22.4 million in Q3, up 3% Q/Q and 88% Y/Y, $1.0 million debt Completed installation of 1 EH/s of nameplate capacity; targeting 1.2 EH/s with additional miners to be installed by the December quarter Targeting initial deployment of immersion cooling technology in the December quarter Invested...

Continue reading

TGS Set to Elevate Gulf of Mexico Operations with Pending Award of Multi-Year Ocean Bottom Node Projects

OSLO, Norway (30 August 2023) – TGS, the leading global provider of energy data and intelligence, today reported a pending award for multiple proprietary Ocean Bottom Node (OBN) projects in the Gulf of Mexico (GoM). The projects will be acquired over a 3-year duration. The negotiations and scope will be finalized during Q3 2023, with the initial project targeted to mobilize in late Q1 2024. Kristian Johansen, CEO at TGS, commented: “This progress and endeavour towards confirming a long-term commitment from a major producer in the Gulf of Mexico and strategic customer reflects our unwavering commitment to innovation and excellence and highlights our ability to adapt to evolving industry needs worldwide. Through our continued focus, service quality and commitment to operating safely and sustainably, we will continue to support the...

Continue reading

Enlight Research and 1Partner Advisory initiate research coverage on EfTEN Real Estate Fund AS

In cooperation with 1Partner Advisory (1PA), Enlight Research published equity research on EfTEN Real Estate Fund AS (EfTEN; EFT1T). The report is attached to the release and can be downloaded on the Enlight Research and EfTEN Real Estate Fund AS websites. In the future, Enlight Research/1PA aims to publish two reports per year on EfTEN. Kristjan Tamla, CEO, EfTEN Capital AS, ”It is a great honor that the most professional equity research house in the Baltics has initiated the coverage of the EfTEN Real Estate Fund AS. Enlight Research reports are highly appreciated by local as well as by international investor communities. It is encouraging to see that robustness of the EfTEN portfolio and EfTEN’s strategy of maintaining low leverage is now also validated by an independent third-party analysis. The Base case Fair value of 21.84 EUR per...

Continue reading

Avance Gas Holding Ltd: Key information relating to the dividend for the second quarter 2023

Bermuda, August 30, 2023 Key information relating to the dividend to be paid by Avance Gas Holding Ltd. for the second quarter 2023: Dividend amount: $0.50 Declared currency: USD Last day including right: September 6, 2023 Ex-date: September 7, 2023 Record date: September 8, 2023 Payment date: September 13, 2023 Date of Approval: August 29, 2023 For further queries, please contact: Randi Navdal Bekkelund, CFOEmail: IR@avancegas.comTel: +47 23 11 40 00 ABOUT AVANCE GASAvance Gas operates in the global market for transportation of liquefied petroleum gas (LPG). The Company is one of the world’s leading owners and operators of very large gas carriers (VLGCs) and operates a fleet of fourteen modern ships including two dual fuel LPG newbuildings for delivery in early 2024. For more information about Avance Gas, please visit www.avancegas.com. This...

Continue reading

Avance Gas Holding Ltd: Second Quarter 2023 Earnings Release

BERMUDA, August 30, 2023 – Avance Gas Holding Ltd (OSE: AGAS) (“Avance Gas” or the “Company”) today reports unaudited results for the second quarter 2023. HIGHLIGHTSThe average time charter equivalent (TCE) rate on load to discharge basis was $52,000/day compared to $58,400/day for the first quarter 2023, ahead of guidance of ~$50,000/day. The TCE basis discharge-to-discharge was $50,800/day also slightly ahead of guidance of ~$50,000/day. For the second quarter, we had a TC coverage of 41% at an average TCE rate of $40,000/day and spot voyages of 59% at $64,500/day. Freight hedging by use of FFA resulted in a loss of $2,500/day for the fleet. Daily operating expenses (OPEX) were $8,000/day, compared to $8,600/day for the first quarter of 2023. Net profit of $35.7 million compared to $36.3 million for the first quarter 2023, or earnings...

Continue reading

Cancer Diagnostic Market to Worth USD 276.8 Billion by 2030 | Skyquest Technology

Cancer diagnostic market is segmented by test, technology, application, end user and product. Based on the test, the cancer diagnostics market is segmented into instrument-based tests, laboratory tests, and liquid biopsies. Based on the application, the cancer diagnostics market is segmented into lung cancer, breast cancer, colorectal cancer, prostate cancer, stomach, liver, esophagus, thyroid, pancreatic cancer, leukemia, and others. Based on the technology, the cancer diagnostics market is bifurcated into platform-based and instrument-based. By test, the market is segmented into hospitals, diagnostic laboratories, and others. Based on product, the cancer diagnostics market is segmented into consumables and instruments- Industry forecast 2023-2030 Westford, USA, Aug. 29, 2023 (GLOBE NEWSWIRE) — According to SkyQuest, the growth...

Continue reading

Razor Energy Corp. Announces Second Quarter Results

NOT FOR DISTRIBUTION TO U.S. NEWS WIRE SERVICES OR DISSEMINATION IN THE UNITED STATES. ANY FAILURE TO COMPLY WITH THIS RESTRICTION MAY CONSTITUTE A VIOLATION OF U.S. SECURITIES LAW. CALGARY, Alberta, Aug. 29, 2023 (GLOBE NEWSWIRE) — Razor Energy Corp. (“Razor” or the “Company”) (TSXV: RZE) announces its second quarter financial and operating results. Selected financial and operational information is outlined below and should be read in conjunction with Razor’s unaudited interim condensed consolidated financial statements, management’s discussion and analysis for the three and six months ended June 30, 2023 which are available on SEDAR at www.sedar.com and the Company’s website www.razor-energy.com. All amounts are expressed in Canadian dollars. Certain metrics, including those expressed on an adjusted basis, are non-IFRS and other...

Continue reading

LSLPharma Group Announces Its Second Quarter Results

The Company continues to focus on increasing its revenues and production capacity43.5% revenue increase to $2.0 million Gross margin of 34%, up significantly from (23%) last year and 19% in the first quarter Adjusted EBITDA1 loss of $260,000 versus $1.4 million loss last year Shareholders’ equity of $10.5 million and net debt of $7.2 million at quarter endBOUCHERVILLE, Quebec, Aug. 29, 2023 (GLOBE NEWSWIRE) — Groupe LSL Pharma Inc. (TSXV: LSL) – (“the Company” or “LSL Pharma Group”), a Canadian integrated pharmaceutical company, announced its financial results for the second quarter ended June 30, 2023. The Company’s Management’s Discussion and Analysis and unaudited consolidated financial statements are available on SEDAR. Unless otherwise specified, all amounts are in Canadian dollars. “We are pleased with these results...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.